ascopubs.org

Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer.

Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, ...
ascopubs.org

LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma.

This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.
ascopubs.org

Recurrence, metastasis, and survival after radical prostatectomy in the era of advanced treatments.

Salvage radiotherapy guided by functional imaging for macroscopic local recurrence following radical prostatectomy: A multicentric retrospective study. Methylated DNA markers in urine aid in the ...
ascopubs.org

Evaluation of tumor marker cancer antigen 72-4 (CA 72-4) in the monitoring of metastatic or recurrent tumors of the gastrointestinal tract, lung, breast, and ovaries.

A study on thromboembolism of patients with pancreatic cancer.
ascopubs.org

Development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors with the immunohistochemistry assay PD-L1 IHC 22C3 pharmDx.

Assay performance of the PD-L1 IHC 28-8 pharmDx assay in squamous cell carcinoma of the head and neck (SCCHN). This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does ...
ascopubs.org

A comparison of Numeric Pain Rating Scale (NPRS) and the Visual Analog Scale (VAS) in patients with chronic cancer-associated pain.

Risk factors and prophylaxis of irinotecan induced cholinergic syndrome in sight of supportive care. This is an ASCO Meeting Abstract from the 2017 Palliative and Supportive Care in Oncology Symposium ...